- Home
- IMRN vs FTEL Comparison
IMRN vs FTEL Comparison
Compare IMRN & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- FTEL
- Stock Information
- Founded
- IMRN 1994
- FTEL 2007
- Country
- IMRN Australia
- FTEL Australia
- Employees
- IMRN N/A
- FTEL N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- FTEL
- Sector
- IMRN Health Care
- FTEL
- Exchange
- IMRN Nasdaq
- FTEL Nasdaq
- Market Cap
- IMRN 9.2M
- FTEL 9.8M
- IPO Year
- IMRN N/A
- FTEL 2023
- Fundamental
- Price
- IMRN $1.81
- FTEL $0.48
- Analyst Decision
- IMRN Strong Buy
- FTEL
- Analyst Count
- IMRN 1
- FTEL 0
- Target Price
- IMRN $5.00
- FTEL N/A
- AVG Volume (30 Days)
- IMRN 82.1K
- FTEL 565.4K
- Earning Date
- IMRN 09-08-2025
- FTEL 08-26-2025
- Dividend Yield
- IMRN N/A
- FTEL N/A
- EPS Growth
- IMRN N/A
- FTEL N/A
- EPS
- IMRN N/A
- FTEL N/A
- Revenue
- IMRN $4,048,286.00
- FTEL $4,990,695.00
- Revenue This Year
- IMRN N/A
- FTEL N/A
- Revenue Next Year
- IMRN N/A
- FTEL N/A
- P/E Ratio
- IMRN N/A
- FTEL N/A
- Revenue Growth
- IMRN 82.90
- FTEL 29.02
- 52 Week Low
- IMRN $1.50
- FTEL $0.36
- 52 Week High
- IMRN $2.87
- FTEL $49.50
- Technical
- Relative Strength Index (RSI)
- IMRN 58.51
- FTEL 40.06
- Support Level
- IMRN $1.62
- FTEL $0.44
- Resistance Level
- IMRN $1.84
- FTEL $0.56
- Average True Range (ATR)
- IMRN 0.09
- FTEL 0.07
- MACD
- IMRN 0.02
- FTEL -0.02
- Stochastic Oscillator
- IMRN 89.55
- FTEL 11.21
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.